Circulating Tumour Cells in Patients With Peritoneal Metastases

Status Completed

Clinical Trial Summary

This study aims to evaluate the prognostic value of circulating tumour cells (CTC) in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy due to gastrointestinal cancers that have spread to the peritoneum.

Clinical Trial Description

CTCs har extracted by way of a new method at baseline, during surgery, and postoperatively. The occurence of such CTCs will be investigated for prognostic evaluation. Patients will be follow-up by Clinical routine. Disease recurrence and overall survival will be the endpoint used. ;

Study Design

Related Conditions & MeSH terms

Circulating Tumor Cell
Hyperthermic Intraperitoneal Chemotherapy
Neoplasm Metastasis
Neoplastic Cells, Circulating
Peritoneal Metastases

Clinical Trial Details

NCT number	NCT04083547
Study type	Observational
Source	Uppsala University
Contact
Status	Completed
Phase
Start date	October 17, 2017
Completion date	November 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03422432` - Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases	N/A
Not yet recruiting	`NCT06295094` - The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.	Phase 2
Recruiting	`NCT05056389` - Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-OXA)	Phase 1
Withdrawn	`NCT03682744` - CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)	Phase 1
Recruiting	`NCT06367270` - The Application of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Surface Malignancies	Phase 2
Recruiting	`NCT05623787` - Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms	N/A
Not yet recruiting	`NCT05095467` - HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction	Phase 2
Recruiting	`NCT06216561` - Intraperitoneal LSTA1 in CRS-HIPEC	Phase 1
Recruiting	`NCT05277766` - Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer	Phase 1
Not yet recruiting	`NCT05318794` - Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer	Phase 2
Completed	`NCT05665257` - Feasibility of Preoperative Inspiratory Muscle Training for Patients With Peritoneal Metastases	N/A
Terminated	`NCT05581719` - A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy	Phase 1/Phase 2
Recruiting	`NCT05379790` - Concomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of Gastric Origin	Phase 1
Recruiting	`NCT04956068` - PIPAC for Peritoneal Metastases	Phase 1
Recruiting	`NCT05204173` - Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis	Phase 2
Recruiting	`NCT04861558` - Efficacy of Hyperthermic Intraperitoneal Chemotherapy	Phase 3
Recruiting	`NCT05340569` - Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.	N/A
Recruiting	`NCT03834272` - Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies	Phase 1/Phase 2
Completed	`NCT03733184` - Development of an IDEAL Framework to Standardise Cytoreductive Surgery for Colorectal Peritoneal Metastases
Recruiting	`NCT06046963` - Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites	Phase 2